Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1973;48:357-364

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ELLIS, L. B.
Right arrow Articles by HARKEN, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ELLIS, L. B.
Right arrow Articles by HARKEN, D. E.

(Circulation. 1973;48:357.)
© 1973 American Heart Association, Inc.


Fifteen-to Twenty-Year Study of One Thousand Patients Undergoing Closed Mitral Valvuloplasty

LAURENCE B. ELLIS M.D.1; JANG B. SINGH M.D.1; DANTE D. MORALES M.D.1; DWIGHT E. HARKEN M.D.1

1 From the Harvard Medical Unit and Thorndike Memorial Laboratory of the Boston City Hospital, the Surgical Service of the Peter Bent Brigham Hospital, the Thoracic Surgical Service of the Mt. Auburn Hospital and the Departments of Medicine and Surgery of the Harvard Medical School.

A study is reported of an annual follow-up over a 15- to 20-year period of the survivors of the first 1,000 patients undergoing closed mitral valvuloplasty for mitral stenosis. In addition to a report of the status of the patients at each year of follow-up, a detailed analysis has been made of the factors influencing results of surgery 15 years after operation. The most important factor adversely influencing long-term results is significant mitral valve calcification. This is true regardless of age, sex, preoperative status, concomitant mitral insufficiency or minor degrees of aortic valve disease. A beneficial effect of younger age (below 40 years at surgery) or lack of associated mitral insufficiency is apparent only in Group III patients with noncalcific valves, and in these two subgroups the results were 41 and 37 percent improved, respectively. These figures do not include the large number of patients who have again been improved following a second or even third operation. Late systemic embolization occurs infrequently after such surgery. (1.1% per patient year of follow-up). In patients without significant valvular calcification and without substantial mitral incompetence or significant associated valvular disease, closed mitral valvuloplasty is the operation of choice. The indications for closed versus open operation for mitral stenosis are discussed in detail.


Key Words: Mitral valve calcification • Systemic embolization • Sex • Age • Mitral insufficiency • Open heart surgery

Submitted on January 25, 1973
Accepted on March 9, 1973




This article has been cited by other articles:


Home page
CirculationHome page
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Circulation, October 7, 2008; 118(15): e523 - e661.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. V. Lichtenstein
Closed heart surgery: Back to the future
J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 941 - 943.
[Full Text] [PDF]


Home page
Eur Heart JHome page
B Iung, E Garbarz, P Michaud, O Fondard, S Helou, J Kamblock, P Berdah, P.-L Michel, P Lionet, B Cormier, et al.
Immediate and mid-term results of repeat percutaneous mitral commissurotomy for restenosis following earlier percutaneous mitral commissurotomy
Eur. Heart J., October 2, 2000; 21(20): 1683 - 1689.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
B. Iung, E. Garbarz, P. Michaud, A. Mahdhaoui, S. Helou, B. Farah, P. Berdah, P.-L. Michel, Y. Makita, B. Cormier, et al.
Percutaneous mitral commissurotomy for restenosis after surgical commissurotomy: Late efficacy and implications for patient selection
J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1295 - 1302.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. B. Farhat, M. Ayari, F. Maatouk, F. Betbout, H. Gamra, M. Jarrar, M. Tiss, S. Hammami, R. Thaalbi, and F. Addad
Percutaneous Balloon Versus Surgical Closed and Open Mitral Commissurotomy : Seven-Year Follow-up Results of a Randomized Trial
Circulation, January 27, 1998; 97(3): 245 - 250.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. E. Orrange, D. T. Kawanishi, B. M. Lopez, S. M. Curry, and S. H. Rahimtoola
Actuarial Outcome After Catheter Balloon Commissurotomy in Patients With Mitral Stenosis
Circulation, January 21, 1997; 95(2): 382 - 389.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
P. Chopra, H. D. Tandon, V. Raizada, N. Gopinath, C. Butler, and R. C. Williams Jr
Comparative Studies of Mitral Valves in Rheumatic Heart Disease
Arch Intern Med, April 1, 1983; 143(4): 661 - 666.
[Abstract] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
C. R. Moraes, M. Arruda, J. R. Lagreca, I. Cavalcanti, E. Victor, and G. Tompson
Mitral Valve Surgery in Children
Vascular and Endovascular Surgery, May 1, 1978; 12(3): 176 - 184.
[PDF]


Home page
Arch SurgHome page
W. S. Buch, R. D. Pipkin, W. D. Hancock, and T. J. Fogarty
Mitral Valve Replacement With the Hancock Stabilized Glutaraldehyde Valve: Clinical and Laboratory Evaluation
Arch Surg, November 1, 1975; 110(11): 1408 - 1415.
[Abstract] [PDF]